Historical aspects of diagnosis and control of diabetes mellitus

Cover Page

Cite item

Full Text

Abstract

Diabetes mellitus is a group of metabolic diseases affecting carbohydrate, lipid, and protein metabolism. This pathology has a long history, and it was considered a disease of the kidneys until the middle of the 19th century. Descriptions have been found in Egyptian papyri, in ancient Indian and Chinese medical literature, in the writings of ancient Greek and Arab doctors. Aretaeus of Cappadocia gave the first accurate description of the disease, coining the term “diabetes”. Thomas Willis first differentiated diabetes from other causes of polyuria by the sweet taste of urine. Matthew Dobson proved the presence of glucose in urine by evaporation. Claude Bernard demonstrated that hyperglycemia contributes to glucosuria. This is how the concept of the renal threshold appeared. In domestic practice, the term "renal threshold" was introduced by endocrinologist V.G. Baranov. The development of qualitative tests for determining glucose in the urine, the creation of test strips and glucometers has significantly improved the quality of life of patients with diabetes. The current stage of development of glucometry includes the determination of fasting plasma glucose, postprandial glycemia, glycated hemoglobin, as well as continuous glucose monitoring. Continuous glucose monitoring systems make it possible to estimate the time in target range, show the rate of rise or fall of glucose levels. It affects the rate and degree of carbohydrate metabolism compensation and allows for maximum control of the disease.

About the authors

Irina A. Kuzina

Sechenov First Moscow State Medical University (Sechenov University)

Email: mia986@mail.ru
ORCID iD: 0000-0001-7923-4894

ассистент каф. эндокринологии Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Ekaterina V. Goncharova

Sechenov First Moscow State Medical University (Sechenov University)

Email: evgoncharova@list.ru
ORCID iD: 0000-0001-7025-8427

канд. мед. наук, доц. каф. эндокринологии Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Narine S. Martirosian

Sechenov First Moscow State Medical University (Sechenov University)

Email: narinarine@list.ru
ORCID iD: 0000-0002-0202-1257

канд. мед. наук, доц. каф. эндокринологии Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Milena E. Telnova

Sechenov First Moscow State Medical University (Sechenov University)

Email: milena.telnova@mail.ru
ORCID iD: 0000-0001-8007-9721

канд. мед. наук, доц., доц. каф. эндокринологии Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Liudmila V. Nedosugova

Sechenov First Moscow State Medical University (Sechenov University)

Email: profmila@mail.ru
ORCID iD: 0000-0002-6823-2487

д-р мед. наук, доц., проф. каф. эндокринологии Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Andrey A. Tulsky

Sechenov First Moscow State Medical University (Sechenov University)

Email: Andrey.a.tulsky@gmail.com
ORCID iD: 0000-0001-9403-265X

студент Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

Nina A. Petunina

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: napetunina@mail.ru
ORCID iD: 0000-0001-9390-1200

чл.-кор. РАН, д-р мед. наук, проф., зав. каф. эндокринологии Института клинической медицины им. Н.В. Склифосовского

Russian Federation, Moscow

References

  1. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Под ред. И.И. Дедова, М.В. Шестаковой, А.Ю. Майорова. 10-й выпуск (дополненный). М., 2021 [Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Pod red. I.I. Dedova, M.V. Shestakovoi, A.Iu. Maiorova. 10-i vypusk (dopolnennyi). Moscow, 2021(in Russian)]. doi: 10.14341/DM12802
  2. IDF. Diabetes Atlas. Tenth edition. 2021.
  3. World Health Organization. Global health estimates: Deaths by cause, age, sex and country, 2000–2012. Geneva: World Health Organization, 2020.
  4. Ebbel B. The Ebers papyrus (p-115). Oxford University Press, Copenhagen and Oxford, 1937.
  5. Karamanou M, Protogerou A, Tsoucalas G, et al. Milestones in the history of diabetes mellitus: The main contributors. World J Diabetes. 2016;7(1):1-7. doi: 10.4239/wjd.v7.i1.1
  6. Laios K, Karamanou M, Saridaki Z, Androutsos G. Aretaeus of Cappadocia and the first description of diabetes. Hormones. 2012;11:109-13. doi: 10.1007/BF03401545
  7. Papaspyros NS. The history of diabetes. The History of Diabetes Mellitus. Second ed. Stuttgart, G. Thieme Verlag, 1964.
  8. Goldman R, Zajac J, Shrestha A, et al. Principles of Diabetes Mellitus. Springer International Publishing, Cham, 2017; p. 3–19. doi: 10.1007/978-3-319-18741-9_1
  9. Willis T. Pharmaceutice rationalis, sive, Diatriba de medicamentorum operationibus in humano corpore. Oxford, 1674.
  10. Eknoyan G, Nagy J. A history of diabetes mellitus or how a disease of the kidneys evolved into a kidney disease. Adv Chronic Kidney Dis. 2005;12(2):223-9. doi: 10.1053/j.ackd.2005.01.002; PMID: 15822058
  11. Moodley N, Ngxamngxa U, Turzyniecka MJ, Pillay TS. Historical perspectives in clinical pathology: a history of glucose measurement. J Clin Pathol. 2015;68(4):258-64. doi: 10.1136/jclinpath-2014-202672; PMID: 25568429
  12. Benedict SR. A reagent for the detection of reducing sugars. J Biol Chem. 1909;5:485-7.
  13. Руководство по клиническим лабораторным исследованиям. Под ред. Е.А. Кост и Л.Г. Смирновой. М., 1964; с. 366 [Rukovodstvo po klinicheskim laboratornym issledovaniiam. Pod red. EA Kost, LG Smirnovoi. Moscow, 1964; p. 366 (in Russian)].
  14. Claude Bernard (1813–1878). J Med Biogr. 2013;21(4):255-6. doi: 10.1177/0967772013508058
  15. Баранов В.Г. Болезни эндокринной системы и обмена веществ: руководство по внутренним болезням. М.: Медицина, 1953 [Baranov VG. Bolezni endokrinnoi sistemy i obmena veshhestv: rukovodstvo po vnutrennim bolezniam. Moscow, 1953 (in Russian)].
  16. Muller D. Studien iiber ein neues Enzym Glykoseoxydase. Biochem Z. 1928;199:136-70.
  17. Comer. Semiquantitative specific test paper for glucose in urine. Anal Chem. 1956;28:1748-50.
  18. Free AH, Adams EC, Kercher ML, et al. Simple specific test for urine glucose. Clin Chem. 1957;3:163-8.
  19. Free AH, Free HM. Self testing, an emerging component of clinical chemistry. Clin Chem. 1984;30:829-38.
  20. Cheah JS, Wong AF. A rapid and simple blood sugar determination using the Ames reflectance meter and Dextrostix system: a preliminary report. Singapore Med J. 1974;15:51-2.
  21. Rahbar S, Blumenfeld О, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun. 1969;36:838-43.
  22. Allen DW, Schroeder WA, Balog J. Observations on the chromatographic heterogeneity of normal adult and fetal human hemoglobin: a study of the effects of crystallization and chromatography on the heterogeneity and isoleucine content. J Am Chem Soc. 1958;80:1628-34.
  23. Peacock I. Glycosylated haemoglobin: measurement and clinical use. J Clin Pathol. 1984;37(8):841-51. doi: 10.1136/jcp.37.8.841; PMID: 6381544; PMCID: PMC498879
  24. Zhang B, Zhang B, Zhou Z, et al. The value of glycosylated hemoglobin in the diagnosis of diabetic retinopathy: a systematic review and Meta-analysis. BMC Endocr Disord. 2021;21(1):82. doi: 10.1186/s12902-021-00737-2
  25. Beck RW, Connor CG, Mullen DM, et al. The Fallacy of Average: How Using HbA1c Alone to Assess Glycemic Control Can Be Misleading. Diabetes Care. 2017;40:994-9. doi: 10.2337/dc17-0636
  26. Beisswenger P, Heine RJ, Leiter LA, et al. Prandial glucose regulation in the glucose triad: Emerging evidence and insights. Endocrine. 2004;25:195-202. doi: 10.1385/ENDO:25:3:195
  27. Bode BW. The Accuracy and Interferences in Self-monitoring of Blood Glucose. US Endocrine Disease. 2007:46-8.
  28. Patton SR. Adherence to glycemic monitoring in diabetes. J Diabetes Sci Technol. 2015;9(3):668-75. doi: 10.1177/1932296814567709
  29. Davis GM, Galindo RJ, Migdal AL, Umpierrez GE. Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia. Endocrinol Metab Clin North Am. 2020;49(1):79-93. doi: 10.1016/j.ecl.2019.11.002
  30. Didyuk O, Econom N, Guardia A, et al. Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation. J Diabetes Sci Technol. 2021;15(3):676-83. doi: 10.1177/1932296819899394
  31. Petrie JR, Peters AL, Bergenstal RM, et al. Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the european association for the study of diabetes and the American diabetes association diabetes technology working group. Diabetes Care. 2017;40(12):1614-21. doi: 10.2337/dci17-0043
  32. Marks BE, Wolfsdorf JI. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol. 2020;11:1-16. doi: 10.3389/fendo.2020.00128
  33. Aronson R, Abitbol A, Tweden KS. First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes. Diabetes Obes Metab. 2019;21(7):1689-94. doi: 10.1111/dom.13726
  34. Hásková A, Radovnická L, Petruželková L, et al. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial. Diabetes Care. 2020;43(11):2744-50. doi: 10.2337/dc20-0112
  35. Wan W, Skandari MR, Minc A, et al. Cost-effectiveness of continuous glucose monitoring for adults with type 1 diabetes compared with self-monitoring of blood glucose: the DIAMOND randomized trial. Diabetes Care. 2018;41(6):1227-34. doi: 10.2337/dc17-1821

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2022 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies